House Committee Hearing Criticizes FDA’s Foreign Inspections Program

Executive Briefing Series
A A
Witnesses at a recent House Oversight and Investigations Subcommittee hearing said the FDA does not know how many foreign manufacturing facilities are exporting drugs to the U.S. and it is unable to inspect them adequately.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00